+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2017-09-19Number of Pages: 191

Nanoemulsion Market (Drug Class - Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials, and Vasodilators; Route of Administration - Topical, Oral, Parenteral, and Nasal; Distribution Channel - Hospital Pharmacies, Retail Pharmacies, and E-commerce) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

Global Nanoemulsion Market: Snapshot

There are various ways in which established players are trying to increase their stronghold over the global market for Nanoemulsion. Expanding outreach in developing markets that offer enormous opportunities to grow is one of them. Besides, they also have a strong pipeline of nanoemulsion based vaccines against influenza, anthrax, chlamydia infection, several sexually transmitted infections, and respiratory diseases.

There are many factors currently boosting the global Nanoemulsion market. Some of them are the technological progress in the pharmaceutical and biotechnology industry, rising instances of chronic diseases, increasing awareness about their treatments, growing demand for more target specific drug delivery systems, and supportive policies of governments. New product launches is also proving to be immensely beneficial for the market.

The other factors responsible for the growth in the market include higher allocations for healthcare infrastructure, rising economic stability, and increasing participation of major market players in in developing economies such as Latin America and the Middle East and Africa.

On account of the aforementioned growth drivers, a report by Transparency Market Research projects the global Nanoemulsion market to rise at a healthy 9.2% CAGR from 2017 and 2025 to become worth US$14.91 bn by 2025 from US$6.78 bn in 2016.
 

 

nanoemulsion market

 

Immunosuppressant See Maximum Uptake

The global market for Nanoemulsion can be segmented based on different parameters. Depending upon the type of drugs, for example, it can be segmented into steroids, anesthetics, NSAIDs, antiretroviral, antimicrobials, vasodilators, immunosuppressant, etc. Of them, the segment of NSAIDs is slated to outpace all others vis-à-vis growth rate by registering a CAGR of 10.1% from 2017 to 2025. This is because of the rising use Nanoemulsion formulation in topical and other drug administration routes for more effective drug delivery allowing for rapid penetration. In terms of market share, however, the segment of immunosuppressant lead the way with 21.3% share in the global Nanoemulsion market in 2016. 

Emphasis on Product Development Drives North America Market

From a geographical perspective, North America at present dominates the global Nanoemulsion market. By expanding at a CAGR of 9.3%, the region is expected to pull in a revenue of US$5.96 bn in 2025. The dominant position of the region is a result of a well-established pharmaceutical and biotechnology industry, thrust on research activities for product development, and increasing prevalence of chronic disorders. Europe trails North America vis-à-vis market share. The revenue in the region is predicted to grow to US$5.217 by 2025.

While Europe and North America are dominant in the Nanoemulsion market in terms of size, Asia Pacific will likely run the show when it comes to growth pace by clocking the maximum CAGR of 9.4% during period between 2017 and 2025. The changing demographics and the increasing incomes of people in the region, particularly in the densely populated countries of China and India, are serving to drive growth in the region.

Latin America is another region that is projected to emerge as a profitable on account of governments’ initiatives to promote pharmaceutical and healthcare industries and the increasing healthcare expenditure. The Middle East and Africa Nanoemulsion market, on the other hand, is expected to grow because of the increasing number of products and initiatives by governments to promote research and development.

Prominent participants operating in the global market for Nanoemulsion are Mitsubishi Tanabe Pharma Corporation, Allergan plc, AbbVie Inc., AstraZeneca Inc., Fresenius Kabi AG, Kaken Pharmaceutical Co., Ltd., GlaxoSmithKline plc, Novartis AG, Sanofi, and B. Braun Melsungen AG.

Global Nanoemulsion Market: Overview

Nanoemulsion based drug products are used for target specific drug delivery as they provide increased bioavailability on the drug molecule at the target site. Nanoemulsion can be used for various applications in treating patients suffering from various disorders such as chronic. Nanoemulsion have been primarily classified into drug class segments: Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials, Vasodilators, and Others. Increasing prevalence of kidney diseases, growing prevalence of chronic diseases, increasing development of vaccines, and technological advancements along with aging population, high demand for minimally invasive procedures are few factors contributing to the growth of the market. The report comprises of an executive summary which delivers information about the nanoemulsion, its segments with market snapshot and comparative analysis by geography, in terms of revenue %, for 2016.

A detailed overview of market dynamics, including the drivers, restraints, and opportunities of the Nanoemulsion market, along with porter’s analysis, pest analysis value chain analysis, of the global market, has been provided in this report. Market revenue analysis for all the above mentioned segments has been provided for the forecast period of 2017-2025, considering 2016 as the base year, and 2015 as the historical year, along with compound annual growth rate (CAGR %), for the forecast period of 2017-2025. Market share estimations were based on in-depth analysis and study of products, and their features etc.

This report provides in-depth analysis of the Nanoemulsion market. The stakeholders for this report include companies involved in the manufacturing of Nanoemulsion. Executive summary section is included snapshot on stakeholders in this report, which summarizes the market size, trends and competition in different regions. Market players and Market share analysis is analyzed to signify percentage share of the major players operating in the Nanoemulsion market. Furthermore, the report includes market attractiveness analysis by geography that depicts the most attractive and significant region in the global market in 2016.

The research methodology is a combination of primary and secondary research. Primary research includes information collected via e-mails, and telephonic interviews of key opinion leaders (KOL), and forms the bulk of our research. Secondary research includes information collected from various sources, by study of company websites, annual reports, stock analysis presentations, press releases, and various national and international databases.  

Global Nanoemulsion Market: Segmentation

Based on drug type, the Nanoemulsion market has been segmented into Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials, Vasodilators, and Others. NSAID drug class is growing at a CAGR of 9.8% from 2017 to 2025 due to increasing use in topical formulation. Based on Route of Administration the Nano emulsion market has been segmented into Topical, Oral, Parenteral, Nasal, Others. Based on Distribution channel Nanoemulsion market has been segmented into Hospital pharmacies, Retail pharmacies, and E-commerce.

Based on geography, the market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The regions are further segmented into major countries which include, U.S., Canada, Germany, U.K., France, Italy, and Spain, rest of Europe, China, Japan, India, Australia, Rest of Asia Pacific, Brazil, Mexico, Rest of Latin America, Saudi Arabia, South Africa, and Rest of Middle East & Africa.

Global Nanoemulsion Market: Competitive Landscape

The report also comprises list of major players in the market, their SWOT analysis, market share of these players in the Nanoemulsion market, key business strategies, product portfolios, and recent developments. Key market players profiled in this report include, Allergan plc. , AbbVie Inc., AstraZeneca Inc., Fresenius Kabi AG, Kaken Pharmaceutical Co., Ltd., Mitsubishi Tanabe Pharma Corporation, GlaxoSmithKline plc., Novartis AG, Sanofi, and B. Braun Melsungen AG.

The Nanoemulsion Market has been segmented as follows:

Nanoemulsion Market, by Drug Class

  • Steroids
  • Anesthetics
  • NSAIDs
  • Immunosuppressant
  • Antiretroviral
  • Antimicrobials
  • Vasodilators
  • Others

Nanoemulsion Market, by Route of Administration

  • Topical
  • Oral
  • Parenteral
  • Nasal
  • Others

Nanoemulsion Market, by Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • E-commerce

 Nanoemulsion Market, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Rest of Middle East & Africa


 
 
Back To Top